Wegovy Rash: Separating the Common from the Concerning

The myth worth correcting first: any rash on Wegovy means an allergic reaction

This is the assumption that sends people reaching for antihistamines or, worse, stopping their injections without telling anyone. In reality, the most common skin reaction to Wegovy is a localised injection-site response — a patch of redness, mild swelling or a small itchy bump exactly where the needle went in. The NHS medicines page for semaglutide lists this as a common side effect, meaning it affects up to one in ten people. It is not an allergy. It is the skin reacting to the mechanical irritation of the injection and to the solution itself, and it almost always fades within a day or two.

Rotating your injection site (abdomen, thigh, upper arm) each week reduces the chance of the skin becoming sensitised in one spot. If you always inject into the same patch, that alone can cause persistent irritation that looks more alarming than it is. The NHS and the Wegovy patient information leaflet both give clear guidance on site rotation; if you have lost your leaflet, your prescriber or pharmacist can point you to the current version on the eMC.

So if you notice a small red mark after your injection that fades in a couple of days, you are most likely in the 'common and harmless' group. Keep a note of it, mention it at your next review, but do not stop your pen without speaking to someone first.

What a genuinely concerning rash looks like on Wegovy

There is a category of skin reaction that warrants the same urgency as a chest pain: a widespread rash appearing across your face, throat, chest or body, particularly one that comes on quickly, within minutes to an hour or two of an injection. If that rash arrives with lip or throat swelling, a feeling that your airway is tightening, or a sudden drop in blood pressure causing dizziness, those are the signs of a serious allergic reaction (anaphylaxis). Call 999. Do not wait for it to settle.

Short of anaphylaxis, a rash spreading beyond the injection site that does not fade within 24 hours, or one that is blistering or peeling, should be reviewed by a doctor the same day, not at your next scheduled prescriber check-in. The MHRA's Yellow Card scheme exists precisely for reactions like these; reporting helps regulators build a clearer picture of how often they occur across the population.

Eczema flares, heat rash and contact dermatitis from an alcohol swab can all mimic a drug reaction. If you have a history of sensitive skin, mention it at your consultation, it is the kind of detail a prescriber factors into their assessment when choosing and monitoring your treatment.

Itching without a visible rash: less discussed, worth knowing

A handful of patients on semaglutide report generalised itching (pruritus in clinical language) without any obvious skin change. It is listed as an uncommon side effect in the Wegovy prescribing information. If it appears in your first few weeks, it often tracks with the GI side effects that many people notice as their body adjusts to the medicine. A useful marker: if the itching is no worse than mildly annoying, comes and goes, and is not accompanied by any visible skin change or swelling, it can reasonably be logged and mentioned at review rather than treated as an emergency.

Where itching persists beyond two to three weeks, intensifies, or keeps disrupting your sleep, flag it with your prescriber before your next scheduled review. Cholestasis (a liver-related bile build-up that causes itching) is rare and would present with other signs, but a clinician can rule it out quickly. The broader question of how semaglutide interacts with different body systems (our semaglutide overview covers the mechanism in plain terms) helps explain why some effects appear in unexpected places.

The practical takeaway: keep a brief phone note when an itch appears, what you were doing, and how long it lasted. It takes thirty seconds before the kettle boils and gives your prescriber genuinely useful information.

When the rash might not be Wegovy at all

Starting a new medicine makes people more alert to physical changes, which is sensible, but also means coincidental rashes get attributed to the injection. Viral rashes, heat rash in warm weather, laundry detergent reactions and insect bites all happen independently of treatment. Before assuming Wegovy is the cause, consider: did the rash appear at the injection site specifically, or somewhere unrelated? Did anything else change around the same time (a new moisturiser, different washing powder, a summer holiday)?

If you are genuinely unsure, photograph the rash and describe it to your prescriber; our wegovy rash pictures page shows examples of typical injection-site reactions alongside more unusual presentations, which can help you judge whether what you are seeing is in the common-and-harmless category. At nume, every repeat order goes through a full clinical review (not a checkbox) so flagging a skin concern between doses is straightforward via our aftercare support team, available seven days a week. For people exploring Wegovy as a treatment option in the first place, our Wegovy guide covers eligibility and what the clinical assessment involves. And if you are comparing skin reactions across GLP-1 medicines, our overview of semaglutide-related rashes sets the broader context.

For anyone considering starting Wegovy, skin history is part of the clinical picture, and if you are wondering whether Wegovy can cause a rash or want a fuller explanation of how Wegovy can cause a skin rash and what drives those reactions, both pages walk through the evidence in detail. It costs nothing to raise it. A free consultation with our prescribers is the right place to do it.